rs587777383
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Variants of the ACTG2 gene correlate with degree of severity and presence of megacystis in chronic intestinal pseudo-obstruction.
|
26813947 |
2016 |
rs587777387
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Variants of the ACTG2 gene correlate with degree of severity and presence of megacystis in chronic intestinal pseudo-obstruction.
|
26813947 |
2016 |
rs797044959
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Variants of the ACTG2 gene correlate with degree of severity and presence of megacystis in chronic intestinal pseudo-obstruction.
|
26813947 |
2016 |
rs869312168
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Variants of the ACTG2 gene correlate with degree of severity and presence of megacystis in chronic intestinal pseudo-obstruction.
|
26813947 |
2016 |
rs587777383
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
New Insights into the Genetics of Fetal Megacystis: ACTG2 Mutations, Encoding γ-2 Smooth Muscle Actin in Megacystis Microcolon Intestinal Hypoperistalsis Syndrome (Berdon Syndrome).
|
25998219 |
2015 |
rs587777387
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
New Insights into the Genetics of Fetal Megacystis: ACTG2 Mutations, Encoding γ-2 Smooth Muscle Actin in Megacystis Microcolon Intestinal Hypoperistalsis Syndrome (Berdon Syndrome).
|
25998219 |
2015 |
rs797044959
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
New Insights into the Genetics of Fetal Megacystis: ACTG2 Mutations, Encoding γ-2 Smooth Muscle Actin in Megacystis Microcolon Intestinal Hypoperistalsis Syndrome (Berdon Syndrome).
|
25998219 |
2015 |
rs587777383
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
De novo ACTG2 mutations cause congenital distended bladder, microcolon, and intestinal hypoperistalsis.
|
24337657 |
2014 |
rs587777383
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Heterozygous de novo and inherited mutations in the smooth muscle actin (ACTG2) gene underlie megacystis-microcolon-intestinal hypoperistalsis syndrome.
|
24676022 |
2014 |
rs587777387
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Heterozygous de novo and inherited mutations in the smooth muscle actin (ACTG2) gene underlie megacystis-microcolon-intestinal hypoperistalsis syndrome.
|
24676022 |
2014 |
rs587777387
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
De novo ACTG2 mutations cause congenital distended bladder, microcolon, and intestinal hypoperistalsis.
|
24337657 |
2014 |
rs797044959
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Heterozygous de novo and inherited mutations in the smooth muscle actin (ACTG2) gene underlie megacystis-microcolon-intestinal hypoperistalsis syndrome.
|
24676022 |
2014 |
rs797044959
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
De novo ACTG2 mutations cause congenital distended bladder, microcolon, and intestinal hypoperistalsis.
|
24337657 |
2014 |
rs1557178535
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs587777386
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs1219107667
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We describe a newborn presenting CSBS intestinal malrotation and chronic intestinal pseudo-obstruction syndrome (CIPS), compound heterozygous for two previously unreported heterozygous mutations in Coxsackie and adenovirus receptor-like membrane protein (CLMP) gene, one in intron 1 (c.28+1G>C), the other on exon 4 (c502C>T, p.R168X).
|
27720179 |
2016 |
rs199529397
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Somehow, this RET R114H mutation proved to have a role in the etiology of both CIPO and HSCR and could contribute to a more diffuse imbalance of gut dysmotility.© 2016 Wiley Periodicals, Inc.
|
27273837 |
2016 |
rs76397662
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Somehow, this RET R114H mutation proved to have a role in the etiology of both CIPO and HSCR and could contribute to a more diffuse imbalance of gut dysmotility.© 2016 Wiley Periodicals, Inc.
|
27273837 |
2016 |
rs6755901
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The minor allele G, at the single nucleotide polymorphism rs6755901, was detected in homozygosity in two patients (28.5%) who had developed chronic intestinal pseudo-obstruction and in 5.5% of the IVF controls.
|
25592315 |
2015 |